Promoting Cholesterol Screening

Not Applicable

Completed

• Conditions: Cardiovascular Diseases; Primary Prevention of Cardiovascular Disease; Lipid Testing

• Registration Number: NCT01930149
• Lead Sponsor: Northwestern University

Brief Summary

Cholesterol screening is an important prerequisite for cardiovascular disease (CVD) risk assessment. Cholesterol screening is recommended by the United States Preventive Services Task Force (USPSTF). Since reminder systems have been shown to modestly improve the rates of preventive services, including in safety net settings, we will implement patient-directed reminders to health center patients who meet our eligibility criteria.

The aim of this study is to determine if a mailed outreach message and facilitated ordering of screening lipid tests increases cholesterol screening test completion within 3 months among federally qualified community health center patients who are eligible for screening compared to usual care.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-08-23
• Study First Submitted QC: 2013-08-23
• Study First Posted: 2013-08-28
• Study Start: 2013-12
• Primary Completion: 2014-03
• Study Completion: 2014-06
• Status Verified: 2014-09
• Last Update Submitted: 2014-09-26
• Last Update Posted: 2014-09-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 480

Inclusion Criteria

• Patient at participating health center
• At least 1 visit to clinic in the prior 12 months
• No total cholesterol and high-density lipoprotein cholesterol result recorded in the electronic health record in the past 5 years
• No cholesterol screening order placed within the previous 3 months
• Men 35-75 years old, or women 45-75 years old who also have one of the following: hypertension, obesity, or current smoking

Exclusion Criteria

• Previously diagnosed cardiovascular disease, peripheral arterial disease or diabetes mellitus
• Statin on active medication list
• Preferred language other than English or Spanish

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Completion of total cholesterol and HDL cholesterol test or full lipid panel	within 3 months of outreach	Primary outcome will be completion of total cholesterol and HDL cholesterol test or a full lipid panel recorded within GE Centricity electronic health record at the patient's clinical site.

Secondary Outcome Measures

Name	Time	Method
Statin prescription	within 3 months of outreach	Secondary outcome is prescription of a statin as assessed by automated electronic queries of electronic health record.

Trial Locations

Locations (3)

North Country Health Care; 🇺🇸 Flagstaff, Arizona, United States

Near North Health Service Corporation; 🇺🇸 Chicago, Illinois, United States

Heartland Health Outreach; 🇺🇸 Chicago, Illinois, United States